The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture
Source
Expert opinion on drug discovery - ISSN 1746-0441-20:12 (2025) p. 1475-1492
The Paraoxonase (PON) gene family in health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and other diseases
Source
International journal of molecular sciences - ISSN 1661-6596-26:22 (2025) p. 1-28
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration
Source
Clinical epigenetics - ISSN 1868-7075-17:1 (2025) p. 1-22
Identification of (epi)genetic risk factors and transcriptional driver mechanisms for obesity and metabolic dysfunction-associated steatotic liver disease
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Biomedical Sciences, 2025,251 p.
Loss of the ubiquitin-associated domain of sqstm1/p62 in zebrafish causes a phenotype resembling Paget’s disease of bone
Source
Calcified tissue international - ISSN 1432-0827-116:1 (2025) p. 1-15